However, cancer cells display much higher ROS levels than normal cells due to dysfunctional mitochondria, oncogene activation and antioxidant imbalance [11,12]; for instance, ROS inactivate PTEN facilitating PI3K, Akt/mTOR signaling, which ultimately leads to tumor progression [13]. Here, MTOR is linked to neoplasm.